Egypt’s dermatological diseases drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Dermatology is defined as a therapy area that deals with diseases of the skin, hair, and nails, where the most common conditions are psoriasis, eczema, and acne vulgaris. Dermatology drugs are used in the management and treatment of diseases related to skin, nails, hair, and genital membranes.
In a study on patterns of skin diseases in Egypt, infections constituted most of the dermatoses (45.4%), and scabies was the most common disease (9.26%). Hypersensitivity diseases came after (22%) and, interestingly, the dermatitis subgroup (12.94%) followed fungal infections (15.83%) immediately, preceding other infection subgroups. Females predominated in most dermatoses. Urticaria predominated in infants, bacterial infections in the preschool stage, fungal infections in school and young adult stages, and dermatitis in old adult and geriatric stages. Acne is a common problem among Egyptian school-aged adolescents with a higher prevalence and impact in females. The demand for the market is will increase in the forecast period.
Rising expenditure on personal care is the vital factor escalating the market growth, also rising awareness towards skin disease, rising number of patients suffering from acne, vitiligo, and dermatitis, rising demand for effective products to cure skin infections and disorders coupled with high awareness among the young population, rising demand for effective dermatological treatments and the increase in a number of companies investing in the market are the major factors among others driving the dermatology drugs market.